StreetInsider.com News Articles

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Define Ventures Appoints Carolyn Magill as Venture Partner

Tue, 11 Mar 2025 05:30:00 -0400

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

SAN MATEO, Calif,--(BUSINESS WIRE)-- Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera’s efforts to scale robotics and AI across mainstream medical procedures.

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Thu, 26 Sep 2024 06:05:00 -0400

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver